{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:33:25Z","timestamp":1786736005941,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijd.ijd_53_18","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T03:04:31Z","timestamp":1573095871000},"page":"447","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of neopterin level and disease severity in patients with psoriasis vulgaris treated with narrowband UVB"],"prefix":"10.4103","volume":"64","author":[{"given":"Funda","family":"Kemeriz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fczeyyen","family":"G\u00f6n\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FatmaPelin","family":"Cengiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazan","family":"Emiro\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beng\u00fc\u00c7evir\u011fen","family":"Cemil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5154.270578-1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2011.07.039","article-title":"Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation","author":"Bae","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.270578-2","first-page":"238","article-title":"Costs and quality of life for psoriatic patients at different degrees of severity in southern Sweden \u2013 A cross-sectional study","author":"Ghatnekar","year":"2012","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/0019-5154.270578-3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2340\/00015555-1673","article-title":"Clinical characteristics associated with illness perception in psoriasis","author":"Wahl","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0019-5154.270578-4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1365-2133.2010.09944.x","article-title":"A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis","author":"Fonia","year":"2010","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.270578-5","first-page":"370","article-title":"No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: A first retrospective study","author":"Weischer","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0019-5154.270578-6","doi-asserted-by":"crossref","unstructured":"Dogra S, De D. Narrowband ultraviolet B in the treatment of psoriasis: The journey so far! Indian J Dermatol Venereol Leprol 2010;76:652-61.","DOI":"10.4103\/0378-6323.72461"},{"key":"key-10.4103\/0019-5154.270578-7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389200024605082","article-title":"Neopterin as a marker for immune system activation","author":"Murr","year":"2002","journal-title":"Curr Drug Metab"},{"key":"key-10.4103\/0019-5154.270578-8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0140-6736(91)91480-I","article-title":"Immune activation and psoriasis","author":"Fuchs","year":"1991","journal-title":"Lancet"},{"key":"key-10.4103\/0019-5154.270578-9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2133.1992.tb14839.x","article-title":"Increased urine neopterin levels in psoriasis","author":"Harland","year":"1992","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.270578-10","first-page":"185","article-title":"Serum neopterin as an objective marker of psoriatic disease activity","author":"Sanchez-Regana","year":"2000","journal-title":"ActaDermVenereol"},{"key":"key-10.4103\/0019-5154.270578-11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2133.2008.08779.x","article-title":"Long-term prognosis in patients with psoriasis","author":"Gulliver","year":"2008","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.270578-12","first-page":"65","article-title":"Psoriasis assessment tools in clinical trials","author":"Feldman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/0019-5154.270578-13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000098568","article-title":"PsoReg \u2013 The Swedish registry for systemic psoriasis treatment.The registry's design and objectives","author":"Schmitt-Egenolf","year":"2007","journal-title":"Dermatology"},{"key":"key-10.4103\/0019-5154.270578-14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1346-8138.2009.00622.x","article-title":"Effects of etanercept on urine neopterin levels in patients with psoriasis in a controlled, open label study","author":"Koc","year":"2009","journal-title":"J Dermatol"},{"key":"key-10.4103\/0019-5154.270578-15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4274\/turkderm.60243","article-title":"Psoriasisdeserum neopterinve TNF-[alpha] d\u00fczeyleri ve hastalik siddeti ile iliskisi\/serum neopterin and TNF-a levels in psoriasis and their correlation with disease severity","author":"Ceyhan","year":"2012","journal-title":"Turkderm"},{"key":"key-10.4103\/0019-5154.270578-16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0190-9622(03)00792-8","article-title":"Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis","author":"Grundmann-Kollmann","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.270578-17","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1365-2133.1999.02898.x","article-title":"The effects of ultraviolet radiation on the human immune system","author":"Duthie","year":"1999","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.270578-18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0923-1811(96)89428-X","article-title":"Neopterin in serum from patient with psoriasis","author":"Okubo","year":"1996","journal-title":"J Dermatol Scie"},{"key":"key-10.4103\/0019-5154.270578-19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000018222","article-title":"Effects of cyclosporin A on immune activation markers in patients with active psoriasis","author":"Economidou","year":"1999","journal-title":"Dermatology"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:36:02Z","timestamp":1786732562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.IJD_53_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"alternative-id":["270578"],"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_53_18","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}